Nurith Aizenman
[Copyright 2024 NPR]
-
Tuberculosis kills 1.6 million a year — the second deadliest infectious disease after COVID-19. Using immune cells and mRNA technology, scientists in South Africa are working on a new vaccine. -
That's the view of Joseph Glauber of the International Food Policy Research Institute. He considers the fear the war would lead to a surge in food prices – and a dramatic worsening of world hunger.
-
The South African-based scientist who co-discovered the omicron variant of COVID-19 makes an intriguing argument. -
Disease researchers from South Africa were the first to identify the omicron variant of the COVID-19 virus. Scientists there are racing to detect new pathogens before they can spark another pandemic.
-
Afrigen is the linchpin of global project to use mRNA technology to empower low-resource countries to make their own vaccines against killer diseases from TB to HIV. What will it take to succeed? -
Dr. Gabriela Kucharski's city of Toledo had virtually no vaccines. And it's a bastion of support for Brazil's vaccine skeptic president. Here's why that didn't matter. -
Can we end poverty, provide food for all and otherwise make Earth a better place by 2030? By all accounts, the answer is no. So then what's the point of the Sustainable Development Goals? -
Only one company makes the currently used monkeypox vaccine. Supply is limited in wealthy nations like the U.S. Less well-off nations, like Nigeria, where the outbreak began, have no vaccines at all. -
How Sotiris Missailidis, head of R&D in Brazil's vaccine agency, used the COVID crisis to push through a game-changing effort for middle-income countries to invent their own mRNA vaccine. -
Pfizer and Moderna have refused to divulge details of how to make their cutting-edge COVID shots. Here's what two scientists — and longtime best friends — are doing about it.
